As of 2024-12-14, the EV/EBITDA ratio of Spire Healthcare Group PLC (SPI.L) is 8.60. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SPI.L's latest enterprise value is 2,125.62 mil GBP. SPI.L's TTM EBITDA according to its financial statements is 247.20 mil GBP. Dividing these 2 quantities gives us the above SPI.L EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 6.2x - 7.3x | 6.8x |
| Forward P/E multiples | 11.0x - 11.3x | 11.1x |
| Fair Price | 82.20 - 307.86 | 207.55 |
| Upside | -63.6% - 36.2% | -8.2% |
| Date | EV/EBITDA |
| 2024-12-13 | 8.60 |
| 2024-12-12 | 8.60 |
| 2024-12-11 | 8.55 |
| 2024-12-10 | 8.55 |
| 2024-12-09 | 8.56 |
| 2024-12-06 | 8.55 |
| 2024-12-05 | 8.57 |
| 2024-12-04 | 8.58 |
| 2024-12-03 | 8.52 |
| 2024-12-02 | 8.53 |
| 2024-11-29 | 8.59 |
| 2024-11-28 | 8.49 |
| 2024-11-27 | 8.46 |
| 2024-11-26 | 8.43 |
| 2024-11-25 | 8.48 |
| 2024-11-22 | 8.49 |
| 2024-11-21 | 8.44 |
| 2024-11-20 | 8.43 |
| 2024-11-19 | 8.50 |
| 2024-11-18 | 8.45 |
| 2024-11-15 | 8.49 |
| 2024-11-14 | 8.48 |
| 2024-11-13 | 8.43 |
| 2024-11-12 | 8.45 |
| 2024-11-11 | 8.50 |
| 2024-11-08 | 8.42 |
| 2024-11-07 | 8.44 |
| 2024-11-06 | 8.46 |
| 2024-11-05 | 8.42 |
| 2024-11-04 | 8.45 |
| 2024-11-01 | 8.48 |
| 2024-10-31 | 8.43 |
| 2024-10-30 | 8.51 |
| 2024-10-29 | 8.47 |
| 2024-10-28 | 8.54 |
| 2024-10-25 | 8.57 |
| 2024-10-24 | 8.67 |
| 2024-10-23 | 8.50 |
| 2024-10-22 | 8.52 |
| 2024-10-21 | 8.56 |
| 2024-10-18 | 8.64 |
| 2024-10-17 | 8.60 |
| 2024-10-16 | 8.57 |
| 2024-10-15 | 8.58 |
| 2024-10-14 | 8.60 |
| 2024-10-11 | 8.58 |
| 2024-10-10 | 8.62 |
| 2024-10-09 | 8.65 |
| 2024-10-08 | 8.64 |
| 2024-10-07 | 8.69 |